Legal Representation
Attorney
Jong H Park
USPTO Deadlines 0 active
All 3 deadline(s) have been cleared by subsequent events.
No active deadlines at this time.
Application History
44 events| Date | Code | Type | Description |
|---|---|---|---|
| Nov 23, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Nov 23, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Nov 23, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Nov 23, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Nov 23, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Aug 19, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Aug 19, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Aug 19, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Aug 19, 2021 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Aug 19, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Aug 19, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Feb 16, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Jan 13, 2021 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Nov 30, 2020 | APET | A | ASSIGNED TO PETITION STAFF |
| Nov 30, 2020 | CHPB | I | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| Oct 9, 2020 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Sep 10, 2020 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Aug 11, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Aug 11, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jul 22, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jul 7, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jul 7, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jul 7, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jun 30, 2020 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Jun 16, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jun 16, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jun 16, 2020 | CNSL | R | SUSPENSION LETTER WRITTEN |
| Jun 16, 2020 | GNSL | S | LETTER OF SUSPENSION E-MAILED |
| Jun 16, 2020 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Jun 12, 2020 | ALIE | A | ASSIGNED TO LIE |
| Jun 4, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| May 21, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| May 21, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| May 21, 2020 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| May 21, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Dec 5, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Dec 5, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Dec 5, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Nov 25, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
| Sep 10, 2019 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Sep 9, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Aug 29, 2019 | NWAP | I | NEW APPLICATION ENTERED |
| Aug 29, 2019 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Aug 29, 2019 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of cells; medicines for human purposes, namely, medicinal preparations for the treatment of cancer; living cells for medical purposes; living cells for veterinary purposes; cells for medical purposes; pharmaceutical preparations for activating cellular function; biological preparations for medical or veterinary purposes for the treatment of cancer; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for health care, namely, nutritional supplements; vaccines; antibodies for veterinary purposes for the treatment of cancers and metabolic disorders; antibodies for medical purposes for the treatment of cancers and metabolic disorders; drugs for medical purposes for the treatment of cancers and metabolic disorders; pharmaceutical preparations for the treatment of cancers with T cells; all the above being for therapeutic purposes; all the above not being for diagnostic purposes"
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the word "TAST" in gray, to the right of a circle combined with four separated pieces, of which the smallest piece at the upper right in light blue color, the piece at the upper left in teal color, the largest piece at the lower left in ocean green color, and the piece at the lower right in cerulean color.
Color Claim
The color(s) gray, light blue, teal, ocean green, and cerulean is/are claimed as a feature of the mark.
Classification
International Classes
005